BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23634887)

  • 21. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Sivars L; Landin D; Haeggblom L; Tertipis N; Grün N; Bersani C; Marklund L; Ghaderi M; Näsman A; Ramqvist T; Nordfors C; Munck-Wikland E; Tani E; Dalianis T
    Head Neck; 2017 Mar; 39(3):419-426. PubMed ID: 27898186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization.
    Nwanze J; Cohen C; Schmitt AC; Siddiqui MT
    Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Papillomavirus DNA Detection by Droplet Digital PCR in Formalin-Fixed Paraffin-Embedded Tumor Tissue from Oropharyngeal Squamous Cell Carcinoma Patients.
    Schiavetto CM; de Abreu PM; von Zeidler SV; de Jesus LM; Carvalho RS; Cirino MT; Carloni AC; Oliveira C; Scapulatempo-Neto C; de Almeida GC; de Menezes NS; Carvalho AL; Reis RM; de Carvalho AC
    Mol Diagn Ther; 2021 Jan; 25(1):59-70. PubMed ID: 33245553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators.
    Park WS; Ryu J; Cho KH; Choi MK; Moon SH; Yun T; Chun BS; Lee GK; Ahn HJ; Lee JH; Vermeer P; Jung YS
    Head Neck; 2012 Oct; 34(10):1408-17. PubMed ID: 22052559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of HPV prevalence in HNSCC patients with regard to regional and socioeconomic factors.
    Krupar R; Hartl M; Wirsching K; Dietmaier W; Strutz J; Hofstaedter F
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1737-45. PubMed ID: 24065189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice.
    Thavaraj S; Stokes A; Guerra E; Bible J; Halligan E; Long A; Okpokam A; Sloan P; Odell E; Robinson M
    J Clin Pathol; 2011 Apr; 64(4):308-12. PubMed ID: 21345874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).
    Rodrigo JP; Heideman DA; García-Pedrero JM; Fresno MF; Brakenhoff RH; Díaz Molina JP; Snijders PJ; Hermsen MA
    Int J Cancer; 2014 Jan; 134(2):487-92. PubMed ID: 23824638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
    Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics of Japanese oropharyngeal squamous cell carcinoma positive for human papillomavirus infection.
    Nomura F; Sugimoto T; Kitagaki K; Ito T; Kawachi H; Eishi Y; Watanabe K; Igaue M; Shimizu N; Tomita M; Kitamura K; Kishimoto S
    Acta Otolaryngol; 2014 Dec; 134(12):1265-74. PubMed ID: 25399886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression.
    Ramshankar V; Soundara VT; Shyamsundar V; Ramani P; Krishnamurthy A
    Asian Pac J Cancer Prev; 2014; 15(19):8351-9. PubMed ID: 25339028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx.
    Śnietura M; Jaworska M; Pigłowski W; Goraj-Zając A; Woźniak G; Lange D
    Pol J Pathol; 2010; 61(3):133-9. PubMed ID: 21225495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of p16
    Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that alpha-9 human papillomavirus infections are a major etiologic factor for oropharyngeal carcinoma in black South Africans.
    Paquette C; Evans MF; Meer SS; Rajendran V; Adamson CS; Cooper K
    Head Neck Pathol; 2013 Dec; 7(4):361-72. PubMed ID: 23797844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
    Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of high-risk HPV DNA PCR, p16
    Simoens C; Gheit T; Ridder R; Gorbaslieva I; Holzinger D; Lucas E; Rehm S; Vermeulen P; Lammens M; Vanderveken OM; Kumar RV; Gangane N; Caniglia A; Maffini F; Rubio MBL; Anantharaman D; Chiocca S; Brennan P; Pillai MR; Sankaranarayanan R; Bogers J; Pawlita M; Tommasino M; Arbyn M;
    BMC Infect Dis; 2022 Aug; 22(1):676. PubMed ID: 35933382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary.
    McDowell LJ; Young RJ; Johnston ML; Tan TJ; Kleid S; Liu CS; Bressel M; Estall V; Rischin D; Solomon B; Corry J
    Cancer; 2016 Apr; 122(8):1201-8. PubMed ID: 26881928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study.
    Bussu F; Sali M; Gallus R; Petrone G; Zannoni GF; Autorino R; Dinapoli N; Santangelo R; Vellone VG; Graziani C; Miccichè F; Almadori G; Galli J; Delogu G; Sanguinetti M; Rindi G; Tommasino M; Valentini V; Paludetti G
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1115-1120. PubMed ID: 25035216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
    Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Brandsma J; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
    J Clin Oncol; 2006 Feb; 24(5):736-47. PubMed ID: 16401683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.